Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 233.73 M241.99 M234.51 M239.85 M256.38 M 972.73 M Research & development 83.24 M85.61 M86.22 M89.52 M97.57 M 358.91 M Operating income -33.26 M-26.62 M-1.72 M9.02 M7.2 M -12.13 M Non-Operating Income, Total 12.72 M11.43 M10.82 M18.52 M41.73 M 82.49 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 12.72 M11.43 M10.82 M18.52 M41.73 M 82.49 M Unusual income/expense ————— — Pretax income -20.53 M-15.19 M9.1 M27.54 M48.93 M 70.36 M Equity in earnings ————— — Taxes 1.59 M1.61 M1.33 M5.5 M4.42 M 12.85 M Non-controlling/minority interest ————— — After tax other income/expense 348 K695 K-4.8 M296 K-610 K -4.42 M Net income before discontinued operations -22.12 M-16.8 M7.77 M22.04 M44.51 M 57.51 M Discontinued operations ————— — Net income -22.12 M-16.8 M7.77 M22.04 M44.51 M 57.51 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -22.12 M-16.8 M7.77 M22.04 M44.51 M 57.51 M Basic earnings per share (Basic EPS) -0.04-0.030.010.040.08 0.1 Diluted earnings per share (Diluted EPS) -0.04-0.030.010.040.08 0.1 Average basic shares outstanding 567.74 M571.74 M575.47 M573.48 M581.84 M — Diluted shares outstanding 567.74 M571.74 M585.64 M573.48 M587.67 M — EBITDA -28.11 M-21.22 M4.35 M16.45 M15.12 M 14.71 M EBIT -33.26 M-26.62 M-1.72 M9.02 M7.2 M -12.13 M Cost of revenue 83.17 M90.5 M96.96 M105.92 M117.7 M 411.08 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 5.14 M5.4 M6.08 M7.43 M7.93 M 26.83 M